Avid Bioservices Inc (CDMO)
6.69
+0.28
(+4.37%)
USD |
NASDAQ |
Apr 23, 16:00
6.69
0.00 (0.00%)
After-Hours: 18:32
Avid Bioservices Cash from Financing (TTM): 9.72M for Oct. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
October 31, 2023 | 9.72M |
July 31, 2023 | 2.72M |
April 30, 2023 | 2.901M |
January 31, 2023 | 2.36M |
October 31, 2022 | 2.603M |
July 31, 2022 | 3.208M |
April 30, 2022 | 3.197M |
January 31, 2022 | 88.34M |
October 31, 2021 | 120.01M |
July 31, 2021 | 118.54M |
April 30, 2021 | 112.34M |
January 31, 2021 | 30.34M |
October 31, 2020 | -3.033M |
July 31, 2020 | -3.292M |
April 30, 2020 | 1.096M |
January 31, 2020 | -3.066M |
October 31, 2019 | -3.521M |
July 31, 2019 | -3.623M |
April 30, 2019 | -2.863M |
January 31, 2019 | 18.85M |
October 31, 2018 | 19.08M |
July 31, 2018 | 19.04M |
April 30, 2018 | 22.25M |
January 31, 2018 | 19.38M |
October 31, 2017 | 24.87M |
Date | Value |
---|---|
July 31, 2017 | 30.16M |
April 30, 2017 | 28.16M |
January 31, 2017 | 11.04M |
October 31, 2016 | 12.63M |
July 31, 2016 | 33.92M |
April 30, 2016 | 41.79M |
January 31, 2016 | 60.88M |
October 31, 2015 | 57.00M |
July 31, 2015 | 34.69M |
April 30, 2015 | 34.98M |
January 31, 2015 | 36.60M |
October 31, 2014 | 61.75M |
July 31, 2014 | 67.53M |
April 30, 2014 | 73.06M |
January 31, 2014 | 65.16M |
October 31, 2013 | 46.21M |
July 31, 2013 | 52.19M |
April 30, 2013 | 38.85M |
January 31, 2013 | 32.28M |
October 31, 2012 | 34.08M |
July 31, 2012 | 30.36M |
April 30, 2012 | 32.01M |
January 31, 2012 | 31.21M |
October 31, 2011 | 34.64M |
July 31, 2011 | 28.41M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.623M
Minimum
Jul 2019
120.01M
Maximum
Oct 2021
25.16M
Average
2.72M
Median
Jul 2023
Cash from Financing (TTM) Benchmarks
Emergent BioSolutions Inc | -535.70M |
Creative Medical Technology Holdings Inc | -0.271M |
Viking Therapeutics Inc | 271.38M |
Stereotaxis Inc | 0.081M |
MAIA Biotechnology Inc | 9.271M |